Detalhe da pesquisa
1.
FOXG1 targets BMP repressors and cell cycle inhibitors in human neural progenitor cells.
Hum Mol Genet
; 32(15): 2511-2522, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216650
2.
Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4).
Hum Mol Genet
; 31(21): 3715-3728, 2022 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640156
3.
Mutations in ACTL6B Cause Neurodevelopmental Deficits and Epilepsy and Lead to Loss of Dendrites in Human Neurons.
Am J Hum Genet
; 104(5): 815-834, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31031012
4.
BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
Pharmacogenomics J
; 19(3): 269-276, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181602
5.
The effect of ethnicity and immigration on treatment resistance in schizophrenia.
Compr Psychiatry
; 89: 28-32, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30579127
6.
Strategies to Advance Drug Discovery in Rare Monogenic Intellectual Disability Syndromes.
Int J Neuropsychopharmacol
; 21(3): 201-206, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29040584
7.
A biopsychosocial evaluation of the risk for suicide in schizophrenia.
CNS Spectr
; 23(4): 253-263, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28535835
8.
Assessing the risk for suicide in schizophrenia according to migration, ethnicity and geographical ancestry.
BMC Psychiatry
; 17(1): 63, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28183281
9.
FOXG1 dose tunes cell proliferation dynamics in human forebrain progenitor cells.
Stem Cell Reports
; 17(3): 475-488, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35148845
10.
Lesch-Nyhan disease causes impaired energy metabolism and reduced developmental potential in midbrain dopaminergic cells.
Stem Cell Reports
; 16(7): 1749-1762, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214487
11.
Stimulation of L-type calcium channels increases tyrosine hydroxylase and dopamine in ventral midbrain cells induced from somatic cells.
Stem Cells Transl Med
; 9(6): 697-712, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154672
12.
FOXG1 Dose in Brain Development.
Front Pediatr
; 7: 482, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31824897
13.
Differentiation of Human Induced Pluripotent Stem Cells (iPSCs) into an Effective Model of Forebrain Neural Progenitor Cells and Mature Neurons.
Bio Protoc
; 9(5): e3188, 2019 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33654990
14.
Validating a research ethnicity questionnaire using genomic markers.
Pharmacogenomics
; 18(18): 1649-1657, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29173001
15.
Classification of suicide attempters in schizophrenia using sociocultural and clinical features: A machine learning approach.
Gen Hosp Psychiatry
; 47: 20-28, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807134
16.
GWAS analysis of treatment resistant schizophrenia: interaction effect of childhood trauma.
Pharmacogenomics
; 18(7): 663-671, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28453389
17.
Polygenic risk score prediction of antipsychotic dosage in schizophrenia.
Schizophr Res
; 170(2-3): 265-70, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26778674
18.
Candidate gene analysis of pharmacodynamic targets for antipsychotic dosage.
Pharmacogenomics
; 17(3): 199-208, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26780210
19.
Does a history of suicide attempt predict higher antipsychotic dosage in schizophrenia?
Psychopharmacology (Berl)
; 231(12): 2507-13, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24402138
20.
Use of candidate gene markers to guide antipsychotic dosage adjustment.
Prog Neuropsychopharmacol Biol Psychiatry
; 54: 315-20, 2014 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25016278